Erythromycin Tablet, Delayed Release
Product Images NDC 13668-588

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 13668-588). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of erythromycin illustrating its molecular arrangement with multiple rings and functional groups, as depicted in the image.*

FDA Label Image

Erythro250mg (Erythro250mg)

Label for Erythromycin Delayed-Release Tablets, USP, 250 mg strength, containing 100 tablets. The label shows storage instructions, dosing notes, manufacturer and labeler information, and a barcode. The product is labeled for prescription use only and manufactured by Torrent Pharma, distributed by Appco Pharma LLC.*

FDA Label Image

Erythro500mg (Erythro500mg)

Label for Erythromycin Delayed-Release Tablets, USP 500 mg, an oral prescription tablet. The label indicates a bottle containing 100 tablets, manufactured for Torrent Pharma Inc. and by Appco Pharma LLC. Directions mention dosing may be taken without regard to meals, with storage and dispensing instructions included.*

FDA Label Image

Torrentlogo (Torrentlogo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.